Young Mother Faces Rare Cancer After Misdiagnosis

A 22-year-old woman from Hemet, California, embarked on an unexpected journey after a trip to Chicago. Aida Burkins, a devoted mother of two children aged 1 and 3, embarked on a nine-month search for answers following an unexpected medical diagnosis.

Unexpected Symptoms Post-Flight

Burkins’ symptoms began after a flight to Chicago in May 2025. She noticed her ear would not pop, a typical reaction expected to resolve after air travel. Upon returning home, her condition worsened. She began experiencing fluid draining into her throat through her nose when bent at a 90-degree angle. Additionally, she suffered from worsening hearing, increased fatigue, and unexplained weight loss.

Initial Misdiagnosis and Further Tests

Initially dismissed as altitude sickness, her condition persisted, urging further medical inquiry. Doctors discovered an obstruction in her Eustachian tube causing the bleeding, leading to a referral to an ENT specialist.

By then, her hearing impairment had intensified with continuous muffled sounds and a persistent ringing. The ENT specialist discovered a mass, suspecting potential cancer, a rare possibility given her age.

Biopsy and Definitive Diagnosis

Awaiting biopsy results for two months, Burkins noticed significant throat swelling impacting her jawline. Her doctor conducted a second biopsy on her neck, confronting a complex, unconventional case.

CT scans revealed numerous abnormal growths in her lymph nodes. Following surgery, a biopsy confirmed her diagnosis of nasopharyngeal carcinoma (NPC) in February 2026.

Understanding Nasopharyngeal Carcinoma

Burkins was informed about NPC, a rare head and neck cancer starting in the nasopharynx, the upper throat behind the nose. Symptoms can include nasal congestion, nosebleeds, hearing loss, persistent ringing in the ears, swollen neck lymph nodes, headaches, and facial pain.

NPC’s rarity in the United States contrasts with its prevalence in East and Southeast Asia, North Africa, and the Arctic. It often relates to Epstein-Barr virus (EBV) infection, genetic predispositions, and environmental influences. In the U.S., the incidence is below one per 100,000 people per year.

Current Treatment and Outlook

Burkins has been receiving chemotherapy and radiation therapy, nearing completion. “My prognosis is overall good,” she shared. Medical evaluations show tumor reduction, prompting optimism for her recovery and eventual cancer-free status.

“Cancer doesn’t discriminate,” Burkins emphasized, alluding to her youth. She aspires to complete her treatment and watch her children grow.

Burkins encourages others experiencing similar symptoms to seek medical advice promptly. Her children remain her motivation through the challenges, offering her resilience and determination to overcome the illness.